APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automated DNA Sequencers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Automated DNA Sequencers Market Outlook and Growth Opportunities 2026

8 January 2026192 pages

Choose your research edition.

Industry ResearchAutomated DNA Sequencers Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Automated DNA Sequencers Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Automated DNA Sequencers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automated DNA Sequencers Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Automated DNA Sequencers Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Automated DNA Sequencers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automated DNA Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automated DNA Sequencers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automated DNA Sequencers market include Roche, Thermo Fisher Scientific, Illumina, Danaher, Agilent Technologies, Beckman Coulter, Abbott Molecular, Promega and QIAGEN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Automated DNA Sequencers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automated DNA Sequencers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automated DNA Sequencers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Automated DNA Sequencers market size, projected growth trends, production technologies, key applications, and end-use industries.

Automated DNA Sequencers Segment by Company

Roche

Thermo Fisher Scientific

Illumina

Danaher

Agilent Technologies

Beckman Coulter

Abbott Molecular

Promega

QIAGEN

Oxford Nanopore Technologies

BGI Group

Berry Genomics

Shanghai Xinzhen

CapitalBio Technology

Automated DNA Sequencers Segment by Type

Chain Terminator DNA Sequencing

Next Generation DNA Sequencing

Automated DNA Sequencers Segment by Application

Pharmaceutical and Biotechnology

Hospitals and Clinics

Scientific Research

Automated DNA Sequencers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automated DNA Sequencers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Automated DNA Sequencers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automated DNA Sequencers significant trends, drivers, influence factors in global and regions.

6. To analyze Automated DNA Sequencers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated DNA Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated DNA Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated DNA Sequencers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Automated DNA Sequencers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automated DNA Sequencers industry.

Chapter 3: Detailed analysis of Automated DNA Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Automated DNA Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Automated DNA Sequencers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automated DNA Sequencers Industry Trends Table 2. Automated DNA Sequencers Industry Drivers Table 3. Automated DNA Sequencers Industry Opportunities and Challenges Table 4. Automated DNA Sequencers Industry Restraints Table 5. Global Automated DNA Sequencers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automated DNA Sequencers Revenue Share by Company (2021-2026) Table 7. Global Automated DNA Sequencers Sales Volume by Company (k units) & (2021-2026) Table 8. Global Automated DNA Sequencers Sales Volume Share by Company (2021-2026) Table 9. Global Automated DNA Sequencers Average Price (USD/unit) of Company (2021-2026) Table 10. Global Automated DNA Sequencers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Automated DNA Sequencers Key Company Manufacturing Base & Headquarters Table 12. Global Automated DNA Sequencers Company, Product Type & Application Table 13. Global Automated DNA Sequencers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Automated DNA Sequencers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chain Terminator DNA Sequencing Table 18. Significant Companies of Next Generation DNA Sequencing Table 19. Global Automated DNA Sequencers Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Automated DNA Sequencers Sales Volume by Type (2021-2026) & (k units) Table 21. Global Automated DNA Sequencers Sales Volume by Type (2027-2032) & (k units) Table 22. Global Automated DNA Sequencers Sales Volume Share by Type (2021-2026) Table 23. Global Automated DNA Sequencers Sales Volume Share by Type (2027-2032) Table 24. Global Automated DNA Sequencers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Automated DNA Sequencers Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Automated DNA Sequencers Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Automated DNA Sequencers Sales Value Share by Type (2021-2026) Table 28. Global Automated DNA Sequencers Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical and Biotechnology Table 30. Significant Companies of Hospitals and Clinics Table 31. Significant Companies of Scientific Research Table 32. Global Automated DNA Sequencers Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Automated DNA Sequencers Sales Volume by Application (2021-2026) & (k units) Table 34. Global Automated DNA Sequencers Sales Volume by Application (2027-2032) & (k units) Table 35. Global Automated DNA Sequencers Sales Volume Share by Application (2021-2026) Table 36. Global Automated DNA Sequencers Sales Volume Share by Application (2027-2032) Table 37. Global Automated DNA Sequencers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Automated DNA Sequencers Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Automated DNA Sequencers Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Automated DNA Sequencers Sales Value Share by Application (2021-2026) Table 41. Global Automated DNA Sequencers Sales Value Share by Application (2027-2032) Table 42. Global Automated DNA Sequencers Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Automated DNA Sequencers Sales by Region (2021-2026) & (k units) Table 44. Global Automated DNA Sequencers Sales Market Share by Region (2021-2026) Table 45. Global Automated DNA Sequencers Sales by Region (2027-2032) & (k units) Table 46. Global Automated DNA Sequencers Sales Market Share by Region (2027-2032) Table 47. Global Automated DNA Sequencers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Automated DNA Sequencers Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Automated DNA Sequencers Sales Value Share by Region (2021-2026) Table 50. Global Automated DNA Sequencers Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Automated DNA Sequencers Sales Value Share by Region (2027-2032) Table 52. Global Automated DNA Sequencers Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Automated DNA Sequencers Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Automated DNA Sequencers Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Automated DNA Sequencers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Automated DNA Sequencers Sales by Country (2021-2026) & (k units) Table 57. Global Automated DNA Sequencers Sales Market Share by Country (2021-2026) Table 58. Global Automated DNA Sequencers Sales by Country (2027-2032) & (k units) Table 59. Global Automated DNA Sequencers Sales Market Share by Country (2027-2032) Table 60. Global Automated DNA Sequencers Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Automated DNA Sequencers Sales Value Market Share by Country (2021-2026) Table 62. Global Automated DNA Sequencers Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Automated DNA Sequencers Sales Value Market Share by Country (2027-2032) Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Roche Automated DNA Sequencers Product Portfolio Table 68. Roche Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Thermo Fisher Scientific Automated DNA Sequencers Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. Illumina Company Information Table 75. Illumina Business Overview Table 76. Illumina Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Illumina Automated DNA Sequencers Product Portfolio Table 78. Illumina Recent Development Table 79. Danaher Company Information Table 80. Danaher Business Overview Table 81. Danaher Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Danaher Automated DNA Sequencers Product Portfolio Table 83. Danaher Recent Development Table 84. Agilent Technologies Company Information Table 85. Agilent Technologies Business Overview Table 86. Agilent Technologies Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Agilent Technologies Automated DNA Sequencers Product Portfolio Table 88. Agilent Technologies Recent Development Table 89. Beckman Coulter Company Information Table 90. Beckman Coulter Business Overview Table 91. Beckman Coulter Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Beckman Coulter Automated DNA Sequencers Product Portfolio Table 93. Beckman Coulter Recent Development Table 94. Abbott Molecular Company Information Table 95. Abbott Molecular Business Overview Table 96. Abbott Molecular Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Abbott Molecular Automated DNA Sequencers Product Portfolio Table 98. Abbott Molecular Recent Development Table 99. Promega Company Information Table 100. Promega Business Overview Table 101. Promega Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Promega Automated DNA Sequencers Product Portfolio Table 103. Promega Recent Development Table 104. QIAGEN Company Information Table 105. QIAGEN Business Overview Table 106. QIAGEN Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. QIAGEN Automated DNA Sequencers Product Portfolio Table 108. QIAGEN Recent Development Table 109. Oxford Nanopore Technologies Company Information Table 110. Oxford Nanopore Technologies Business Overview Table 111. Oxford Nanopore Technologies Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Oxford Nanopore Technologies Automated DNA Sequencers Product Portfolio Table 113. Oxford Nanopore Technologies Recent Development Table 114. BGI Group Company Information Table 115. BGI Group Business Overview Table 116. BGI Group Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BGI Group Automated DNA Sequencers Product Portfolio Table 118. BGI Group Recent Development Table 119. Berry Genomics Company Information Table 120. Berry Genomics Business Overview Table 121. Berry Genomics Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Berry Genomics Automated DNA Sequencers Product Portfolio Table 123. Berry Genomics Recent Development Table 124. Shanghai Xinzhen Company Information Table 125. Shanghai Xinzhen Business Overview Table 126. Shanghai Xinzhen Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Shanghai Xinzhen Automated DNA Sequencers Product Portfolio Table 128. Shanghai Xinzhen Recent Development Table 129. CapitalBio Technology Company Information Table 130. CapitalBio Technology Business Overview Table 131. CapitalBio Technology Automated DNA Sequencers Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. CapitalBio Technology Automated DNA Sequencers Product Portfolio Table 133. CapitalBio Technology Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Automated DNA Sequencers Distributors List Table 137. Automated DNA Sequencers Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Automated DNA Sequencers Product Image Figure 2. Global Automated DNA Sequencers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Automated DNA Sequencers Sales (2021-2032) & (k units) Figure 5. Global Automated DNA Sequencers Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Automated DNA Sequencers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chain Terminator DNA Sequencing Image Figure 10. Next Generation DNA Sequencing Image Figure 11. Global Automated DNA Sequencers Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Automated DNA Sequencers Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Automated DNA Sequencers Sales Volume Share by Type (2021-2032) Figure 14. Global Automated DNA Sequencers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Automated DNA Sequencers Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Automated DNA Sequencers Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical and Biotechnology Image Figure 18. Hospitals and Clinics Image Figure 19. Scientific Research Image Figure 20. Global Automated DNA Sequencers Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Automated DNA Sequencers Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Automated DNA Sequencers Sales Volume Share by Application (2021-2032) Figure 23. Global Automated DNA Sequencers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Automated DNA Sequencers Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Automated DNA Sequencers Sales Value Share by Application (2021-2032) Figure 26. Global Automated DNA Sequencers Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Automated DNA Sequencers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Automated DNA Sequencers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Automated DNA Sequencers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 31. North America Automated DNA Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Automated DNA Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Automated DNA Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 37. South America Automated DNA Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Automated DNA Sequencers Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Automated DNA Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Automated DNA Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Automated DNA Sequencers Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Automated DNA Sequencers Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Chain Terminator DNA Sequencing
  • Next Generation DNA Sequencing
Applications
  • Pharmaceutical and Biotechnology
  • Hospitals and Clinics
  • Scientific Research
Companies covered
  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • Danaher
  • Agilent Technologies
  • Beckman Coulter
  • Abbott Molecular
  • Promega
  • QIAGEN
  • Oxford Nanopore Technologies
  • BGI Group
  • Berry Genomics
  • Shanghai Xinzhen
  • CapitalBio Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Automated DNA Sequencers Sales Value (2021-2032)
  4. 1.2.2 Global Automated DNA Sequencers Sales Volume (2021-2032)
  5. 1.2.3 Global Automated DNA Sequencers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Automated DNA Sequencers Market Dynamics
  1. 2.1 Automated DNA Sequencers Industry Trends
  2. 2.2 Automated DNA Sequencers Industry Drivers
  3. 2.3 Automated DNA Sequencers Industry Opportunities and Challenges
  4. 2.4 Automated DNA Sequencers Industry Restraints
3 Automated DNA Sequencers Market by Company
  1. 3.1 Global Automated DNA Sequencers Company Revenue Ranking in 2025
  2. 3.2 Global Automated DNA Sequencers Revenue by Company (2021-2026)
  3. 3.3 Global Automated DNA Sequencers Sales Volume by Company (2021-2026)
  4. 3.4 Global Automated DNA Sequencers Average Price by Company (2021-2026)
  5. 3.5 Global Automated DNA Sequencers Company Ranking (2024-2026)
  6. 3.6 Global Automated DNA Sequencers Company Manufacturing Base and Headquarters
  7. 3.7 Global Automated DNA Sequencers Company Product Type and Application
  8. 3.8 Global Automated DNA Sequencers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Automated DNA Sequencers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Automated DNA Sequencers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Automated DNA Sequencers Market by Type
  1. 4.1 Automated DNA Sequencers Type Introduction
  2. 4.1.1 Chain Terminator DNA Sequencing
  3. 4.1.2 Next Generation DNA Sequencing
  4. 4.2 Global Automated DNA Sequencers Sales Volume by Type
  5. 4.2.1 Global Automated DNA Sequencers Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Automated DNA Sequencers Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Automated DNA Sequencers Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Automated DNA Sequencers Sales Value by Type
  9. 4.3.1 Global Automated DNA Sequencers Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Automated DNA Sequencers Sales Value by Type (2021-2032)
  11. 4.3.3 Global Automated DNA Sequencers Sales Value Share by Type (2021-2032)
5 Automated DNA Sequencers Market by Application
  1. 5.1 Automated DNA Sequencers Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology
  3. 5.1.2 Hospitals and Clinics
  4. 5.1.3 Scientific Research
  5. 5.2 Global Automated DNA Sequencers Sales Volume by Application
  6. 5.2.1 Global Automated DNA Sequencers Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Automated DNA Sequencers Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Automated DNA Sequencers Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Automated DNA Sequencers Sales Value by Application
  10. 5.3.1 Global Automated DNA Sequencers Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Automated DNA Sequencers Sales Value by Application (2021-2032)
  12. 5.3.3 Global Automated DNA Sequencers Sales Value Share by Application (2021-2032)
6 Automated DNA Sequencers Regional Sales and Value Analysis
  1. 6.1 Global Automated DNA Sequencers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automated DNA Sequencers Sales by Region (2021-2032)
  3. 6.2.1 Global Automated DNA Sequencers Sales by Region: 2021-2026
  4. 6.2.2 Global Automated DNA Sequencers Sales by Region (2027-2032)
  5. 6.3 Global Automated DNA Sequencers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Automated DNA Sequencers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Automated DNA Sequencers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Automated DNA Sequencers Sales Value by Region (2027-2032)
  9. 6.5 Global Automated DNA Sequencers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Automated DNA Sequencers Sales Value (2021-2032)
  12. 6.6.2 North America Automated DNA Sequencers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Automated DNA Sequencers Sales Value (2021-2032)
  15. 6.7.2 Europe Automated DNA Sequencers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Automated DNA Sequencers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Automated DNA Sequencers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Automated DNA Sequencers Sales Value (2021-2032)
  21. 6.9.2 South America Automated DNA Sequencers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Automated DNA Sequencers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Automated DNA Sequencers Sales Value Share by Country, 2025 VS 2032
7 Automated DNA Sequencers Country-level Sales and Value Analysis
  1. 7.1 Global Automated DNA Sequencers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automated DNA Sequencers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Automated DNA Sequencers Sales by Country (2021-2032)
  4. 7.3.1 Global Automated DNA Sequencers Sales by Country (2021-2026)
  5. 7.3.2 Global Automated DNA Sequencers Sales by Country (2027-2032)
  6. 7.4 Global Automated DNA Sequencers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Automated DNA Sequencers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Automated DNA Sequencers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Automated DNA Sequencers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Automated DNA Sequencers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Automated DNA Sequencers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Automated DNA Sequencers Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Automated DNA Sequencers Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Automated DNA Sequencers Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 Danaher
  20. 8.4.1 Danaher Company Information
  21. 8.4.2 Danaher Business Overview
  22. 8.4.3 Danaher Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Danaher Automated DNA Sequencers Product Portfolio
  24. 8.4.5 Danaher Recent Developments
  25. 8.5 Agilent Technologies
  26. 8.5.1 Agilent Technologies Company Information
  27. 8.5.2 Agilent Technologies Business Overview
  28. 8.5.3 Agilent Technologies Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Agilent Technologies Automated DNA Sequencers Product Portfolio
  30. 8.5.5 Agilent Technologies Recent Developments
  31. 8.6 Beckman Coulter
  32. 8.6.1 Beckman Coulter Company Information
  33. 8.6.2 Beckman Coulter Business Overview
  34. 8.6.3 Beckman Coulter Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beckman Coulter Automated DNA Sequencers Product Portfolio
  36. 8.6.5 Beckman Coulter Recent Developments
  37. 8.7 Abbott Molecular
  38. 8.7.1 Abbott Molecular Company Information
  39. 8.7.2 Abbott Molecular Business Overview
  40. 8.7.3 Abbott Molecular Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abbott Molecular Automated DNA Sequencers Product Portfolio
  42. 8.7.5 Abbott Molecular Recent Developments
  43. 8.8 Promega
  44. 8.8.1 Promega Company Information
  45. 8.8.2 Promega Business Overview
  46. 8.8.3 Promega Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Promega Automated DNA Sequencers Product Portfolio
  48. 8.8.5 Promega Recent Developments
  49. 8.9 QIAGEN
  50. 8.9.1 QIAGEN Company Information
  51. 8.9.2 QIAGEN Business Overview
  52. 8.9.3 QIAGEN Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 QIAGEN Automated DNA Sequencers Product Portfolio
  54. 8.9.5 QIAGEN Recent Developments
  55. 8.10 Oxford Nanopore Technologies
  56. 8.10.1 Oxford Nanopore Technologies Company Information
  57. 8.10.2 Oxford Nanopore Technologies Business Overview
  58. 8.10.3 Oxford Nanopore Technologies Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Oxford Nanopore Technologies Automated DNA Sequencers Product Portfolio
  60. 8.10.5 Oxford Nanopore Technologies Recent Developments
  61. 8.11 BGI Group
  62. 8.11.1 BGI Group Company Information
  63. 8.11.2 BGI Group Business Overview
  64. 8.11.3 BGI Group Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BGI Group Automated DNA Sequencers Product Portfolio
  66. 8.11.5 BGI Group Recent Developments
  67. 8.12 Berry Genomics
  68. 8.12.1 Berry Genomics Company Information
  69. 8.12.2 Berry Genomics Business Overview
  70. 8.12.3 Berry Genomics Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Berry Genomics Automated DNA Sequencers Product Portfolio
  72. 8.12.5 Berry Genomics Recent Developments
  73. 8.13 Shanghai Xinzhen
  74. 8.13.1 Shanghai Xinzhen Company Information
  75. 8.13.2 Shanghai Xinzhen Business Overview
  76. 8.13.3 Shanghai Xinzhen Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Xinzhen Automated DNA Sequencers Product Portfolio
  78. 8.13.5 Shanghai Xinzhen Recent Developments
  79. 8.14 CapitalBio Technology
  80. 8.14.1 CapitalBio Technology Company Information
  81. 8.14.2 CapitalBio Technology Business Overview
  82. 8.14.3 CapitalBio Technology Automated DNA Sequencers Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 CapitalBio Technology Automated DNA Sequencers Product Portfolio
  84. 8.14.5 CapitalBio Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Automated DNA Sequencers Value Chain Analysis
  2. 9.1.1 Automated DNA Sequencers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Automated DNA Sequencers Sales Mode & Process
  6. 9.2 Automated DNA Sequencers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Automated DNA Sequencers Distributors
  9. 9.2.3 Automated DNA Sequencers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst